Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. (Q54340131)

28 May 2018

title

Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. (English)

1 reference

28 May 2018

1 reference

4

1 reference

28 May 2018

author name string

Wen-Ling Kuo

1

1 reference

28 May 2018

Ming-Chin Yu

2

1 reference

28 May 2018

Ju-Fang Lee

3

1 reference

28 May 2018

Tse-Ching Chen

5

1 reference

28 May 2018

Miin-Fu Chen

6

1 reference

28 May 2018

publication date

9 November 2011

1 reference

28 May 2018

Journal of Gastrointestinal Surgery

published in

1 reference

28 May 2018

volume

16

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

361-369

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s11605-011-1764-7

exact match

0 references

cites work

Molecular mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Reversal of hepatic fibrosis -- fact or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1764-7

Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.

21 January 2018

1 reference

12 December 2020

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

1 reference

12 December 2020

Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats

1 reference

12 December 2020

Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats

1 reference

12 December 2020

Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C

1 reference

12 December 2020

The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression

1 reference

12 December 2020

Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced byIn Vivo liver injury in the rat

1 reference

12 December 2020

CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs

1 reference

12 December 2020

The canals of hering might represent a target of methotrexate hepatic toxicity

1 reference

12 December 2020

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors

1 reference

12 December 2020

Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro

1 reference

12 December 2020

10.1007/S11605-011-1764-7

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018